Related Experiment Video

Updated: Jun 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The role of statins in managing diabetic dyslipidemia

Peter P Toth1

  • 1Sterling Rock Falls Clinic, Ltd., Sterling, Illinois, USA.

The Journal of Family Practice
|June 15, 2010
PubMed

Insights

Patients with type 2 diabetes mellitus (T2DM) have high cardiovascular (CV) risk due to lipid issues. Statins can help, but many T2DM patients aren't treated or reaching lipid goals, requiring better care strategies.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) is frequently associated with dyslipidemia.
  • These lipid abnormalities significantly increase cardiovascular (CV) risk in patients with T2DM.
  • Statins are a proven therapy for reducing atherogenic burden and improving CV outcomes.

Purpose of the Study:

  • To highlight the unmet need in statin therapy for patients with T2DM.
  • To emphasize the importance of achieving lipid targets in this high-risk population.
  • To advocate for improved care strategies for T2DM patients at CV risk.

Main Methods:

  • Review of current clinical guidelines and evidence regarding lipid management in T2DM.
  • Analysis of treatment gaps and challenges in statin utilization and efficacy.
  • Discussion of strategies to enhance CV risk reduction in T2DM.

Main Results:

  • A significant proportion of patients with T2DM are undertreated with statins.
  • Many patients on statin therapy do not achieve recommended lipid targets.
  • Suboptimal lipid management contributes to persistent high CV risk.

Conclusions:

  • Improved implementation of statin therapy is crucial for T2DM patients.
  • Aggressive lipid-lowering strategies are necessary to mitigate CV risk.
  • Enhanced quality of care is essential to prevent primary and secondary CV events in this population.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...